Lyra Therapeutics Announces Closing of $50.0 Million

WATERTOWN, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology...

Related Keywords

Ukraine ,United States ,Russia ,Ellen Cavaleri ,Maria Palasis ,Harlanw Waksal ,Hc Wainwright Co ,Cantor Fitzgerald Co ,William Blair Company ,Nasdaq ,While The Company ,Lyra Therapeutics Inc ,Company Quarterly Report On Form ,Perceptive Advisors ,Venrock Healthcare Capital Partners ,Armistice Capital ,Surveyor Capital ,North Bridge Venture Partners ,Nantahala Capital ,Samsara Biocapital ,Woodline Partners ,Chief Executive Officer ,Executive Chairman ,William Blair ,Securities Act ,Private Securities Litigation Reform Act ,Quarterly Report ,Investor Relations ,Nasdaq Lyra ,Lyra Therapeutics ,